-
Product Insights
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) - Global Clinical Trials Review, 2025" provides an overview of Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
Reflux Esophagitis (Gastroesophageal Reflux Disease): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Reflux Esophagitis (Gastroesophageal Reflux Disease) - Global Clinical Trials Review, 2025" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Dry (Atrophic) Macular Degeneration: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2025" provides an overview of Dry (Atrophic) Macular Degeneration Clinical trials scenario. This report provides top line data relating to the clinical trials on Dry (Atrophic) Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
IgA Nephropathy (Berger's Disease): Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2025" provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top line data relating to the clinical trials on IgA Nephropathy (Berger's Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Malnutrition: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Malnutrition - Global Clinical Trials Review, 2025" provides an overview of Malnutrition Clinical trials scenario. This report provides top line data relating to the clinical trials on Malnutrition. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Lupus Nephritis: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Lupus Nephritis - Global Clinical Trials Review, 2025" provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Monkeypox: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Monkeypox - Global Clinical Trials Review, 2025" provides an overview of Monkeypox Clinical trials scenario. This report provides top line data relating to the clinical trials on Monkeypox. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cytopenia: Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Cytopenia - Global Clinical Trials Review, 2025" provides an overview of Cytopenia Clinical trials scenario. This report provides top line data relating to the clinical trials on Cytopenia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Thematic Analysis
Pharma M&A Deals Q3 2025 - Top Themes: Strategic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q3 2025 in the pharma Sector.
-
Sector Analysis
Hypoglycemia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Hypoglycemia Therapeutics. • In 2024 and 2029, India is estimated to have the highest number of diagnosed incident cases of hypoglycemia, representing a large portion of global cases. • Novo Nordisk’s GlucaGen (glucagon hypokit) and Eli Lilly’s Glucagon had been the primary marketed glucagons for decades. • The hypoglycemia pipeline holds 16 molecules, with no assets in the pre-registration stage, three assets in Phase III development,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.